Yizhun Intelligent Completes $14 Million B Round for AI-based Scaning Diagnosis
publication date: Mar 19, 2020
Yizhun Intelligent, a Beijing AI-based medical scan diagnosis company, completed a Series B funding round of $14 million, led by Wondfo Bio-industry Fund and joined by existing investors Hina Group and Qingsong Fund. Founded in 2017, Yizhun uses machine learning to develop products. So far, the company has launched intelligent detection systems for lung nodules, mammography targets and several lung diseases. It also partnered with IBM Watson to create an AI medical imaging research platform called the "Darwin Intelligent Scientific Research Platform." Its products are used in over 400 China hospitals. More details....
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.